25 XP   0   0   10

Uscom Ltd
Buy, Hold or Sell?

Let's analyse Uscom together

PenkeI guess you are interested in Uscom Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Uscom Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Uscom Ltd

I send you an email if I find something interesting about Uscom Ltd.

Quick analysis of Uscom (30 sec.)










What can you expect buying and holding a share of Uscom? (30 sec.)

How much money do you get?

How much money do you get?
A$0.01
When do you have the money?
1 year
How often do you get paid?
40.0%

What is your share worth?

Current worth
A$0.01
Expected worth in 1 year
A$-0.03
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
A$-0.04
Return On Investment
-119.8%

For what price can you sell your share?

Current Price per Share
A$0.03
Expected price per share
A$0.03 - A$0.034
How sure are you?
50%

1. Valuation of Uscom (5 min.)




Live pricePrice per Share (EOD)

A$0.03

Intrinsic Value Per Share

A$-0.09 - A$-0.01

Total Value Per Share

A$-0.08 - A$0.00

2. Growth of Uscom (5 min.)




Is Uscom growing?

Current yearPrevious yearGrowGrow %
How rich?$1.9m$3.8m-$1.8m-95.0%

How much money is Uscom making?

Current yearPrevious yearGrowGrow %
Making money-$1.6m-$1.2m-$399.1k-23.9%
Net Profit Margin-97.2%-78.6%--

How much money comes from the company's main activities?

3. Financial Health of Uscom (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#284 / 334

Most Revenue
#248 / 334

Most Profit
#161 / 334

Most Efficient
#239 / 334

What can you expect buying and holding a share of Uscom? (5 min.)

Welcome investor! Uscom's management wants to use your money to grow the business. In return you get a share of Uscom.

What can you expect buying and holding a share of Uscom?

First you should know what it really means to hold a share of Uscom. And how you can make/lose money.

Speculation

The Price per Share of Uscom is A$0.031. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Uscom.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Uscom, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.01. Based on the TTM, the Book Value Change Per Share is A$-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Uscom.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.01-22.0%-0.01-22.0%-0.01-16.8%0.00-14.0%0.00-14.1%
Usd Book Value Change Per Share-0.01-24.6%-0.01-24.6%0.0124.3%0.00-3.1%0.000.6%
Usd Dividend Per Share0.005.3%0.005.3%0.0134.0%0.008.8%0.004.4%
Usd Total Gains Per Share-0.01-19.3%-0.01-19.3%0.0258.3%0.005.7%0.005.0%
Usd Price Per Share0.03-0.03-0.04-0.08-0.10-
Price to Earnings Ratio-4.34--4.34--8.06--23.56--26.82-
Price-to-Total Gains Ratio-4.95--4.95-2.32--99.03--46.39-
Price to Book Ratio3.70-3.70-2.68-8.78-11.27-
Price-to-Total Gains Ratio-4.95--4.95-2.32--99.03--46.39-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0200012
Number of shares49997
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (49997 shares)-299.5988.60
Gains per Year (49997 shares)-1,198.35354.40
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1327-1525-1208544-190344
2654-3051-24061089-380698
3981-4576-36041633-5701052
41308-6101-48022178-7601406
51635-7626-60002722-9501760
61961-9152-71983266-11402114
72288-10677-83963811-13302468
82615-12202-95944355-15202822
92942-13727-107924900-17103176
103269-15253-119905444-19003530

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.019.02.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%4.06.00.040.0%7.014.00.033.3%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%4.00.01.080.0%4.00.06.040.0%4.00.017.019.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%5.05.00.050.0%8.013.00.038.1%

Fundamentals of Uscom

About Uscom Ltd

Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices worldwide. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function using Doppler ultrasound; BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, as well as in the arm; and SpiroSonic, a pulmonary function testing device based on multi-path ultrasound technology. The company also provides the SpiroSonic AIR, a technology based on digital transit-time ultrasound comprising enhanced wireless and internet connectivity that allows clinicians to interface with several proprietary apps and software platforms; eHealth, which profiles cardiovascular and pulmonary function in a novel way; and respiratory devices. It serves hospitals and other medical care locations through a network of distribution partners. The company was formerly known as Uscom Pty Limited and changed its name to Uscom Limited in October 2003. The company was incorporated in 1999 and is headquartered in Sydney, Australia.

Fundamental data was last updated by Penke on 2024-04-09 06:13:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Uscom Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Uscom earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Uscom to the Medical Devices industry mean.
  • A Net Profit Margin of -97.2% means that $-0.97 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Uscom Ltd:

  • The MRQ is -97.2%. The company is making a huge loss. -2
  • The TTM is -97.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-97.2%TTM-97.2%0.0%
TTM-97.2%YOY-78.6%-18.7%
TTM-97.2%5Y-57.4%-39.9%
5Y-57.4%10Y-74.5%+17.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-97.2%-12.4%-84.8%
TTM-97.2%-20.4%-76.8%
YOY-78.6%-14.8%-63.8%
5Y-57.4%-21.3%-36.1%
10Y-74.5%-25.0%-49.5%
1.1.2. Return on Assets

Shows how efficient Uscom is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Uscom to the Medical Devices industry mean.
  • -50.0% Return on Assets means that Uscom generated $-0.50 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Uscom Ltd:

  • The MRQ is -50.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -50.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-50.0%TTM-50.0%0.0%
TTM-50.0%YOY-24.7%-25.3%
TTM-50.0%5Y-29.6%-20.4%
5Y-29.6%10Y-34.0%+4.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-50.0%-4.1%-45.9%
TTM-50.0%-4.7%-45.3%
YOY-24.7%-4.8%-19.9%
5Y-29.6%-4.0%-25.6%
10Y-34.0%-5.2%-28.8%
1.1.3. Return on Equity

Shows how efficient Uscom is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Uscom to the Medical Devices industry mean.
  • -85.1% Return on Equity means Uscom generated $-0.85 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Uscom Ltd:

  • The MRQ is -85.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -85.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-85.1%TTM-85.1%0.0%
TTM-85.1%YOY-33.2%-51.9%
TTM-85.1%5Y-45.4%-39.7%
5Y-45.4%10Y-45.3%-0.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-85.1%-4.2%-80.9%
TTM-85.1%-5.8%-79.3%
YOY-33.2%-5.7%-27.5%
5Y-45.4%-6.3%-39.1%
10Y-45.3%-7.1%-38.2%

1.2. Operating Efficiency of Uscom Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Uscom is operating .

  • Measures how much profit Uscom makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Uscom to the Medical Devices industry mean.
  • An Operating Margin of -109.5% means the company generated $-1.09  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Uscom Ltd:

  • The MRQ is -109.5%. The company is operating very inefficient. -2
  • The TTM is -109.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-109.5%TTM-109.5%0.0%
TTM-109.5%YOY-103.8%-5.7%
TTM-109.5%5Y-70.1%-39.4%
5Y-70.1%10Y-86.3%+16.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-109.5%-24.3%-85.2%
TTM-109.5%-16.4%-93.1%
YOY-103.8%-13.7%-90.1%
5Y-70.1%-19.9%-50.2%
10Y-86.3%-24.5%-61.8%
1.2.2. Operating Ratio

Measures how efficient Uscom is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 2.09 means that the operating costs are $2.09 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Uscom Ltd:

  • The MRQ is 2.095. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.095. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.095TTM2.0950.000
TTM2.095YOY2.038+0.057
TTM2.0955Y1.757+0.337
5Y1.75710Y1.954-0.196
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0951.442+0.653
TTM2.0951.439+0.656
YOY2.0381.431+0.607
5Y1.7571.436+0.321
10Y1.9541.374+0.580

1.3. Liquidity of Uscom Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Uscom is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 3.08 means the company has $3.08 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Uscom Ltd:

  • The MRQ is 3.080. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.080. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.080TTM3.0800.000
TTM3.080YOY7.045-3.965
TTM3.0805Y4.427-1.347
5Y4.42710Y4.876-0.449
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.0802.726+0.354
TTM3.0802.732+0.348
YOY7.0453.510+3.535
5Y4.4273.617+0.810
10Y4.8763.499+1.377
1.3.2. Quick Ratio

Measures if Uscom is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Uscom to the Medical Devices industry mean.
  • A Quick Ratio of 2.71 means the company can pay off $2.71 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Uscom Ltd:

  • The MRQ is 2.706. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.706. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.706TTM2.7060.000
TTM2.706YOY9.437-6.730
TTM2.7065Y4.129-1.423
5Y4.12910Y3.899+0.230
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7061.491+1.215
TTM2.7061.633+1.073
YOY9.4372.113+7.324
5Y4.1292.295+1.834
10Y3.8992.255+1.644

1.4. Solvency of Uscom Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Uscom assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Uscom to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.41 means that Uscom assets are financed with 41.2% credit (debt) and the remaining percentage (100% - 41.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Uscom Ltd:

  • The MRQ is 0.412. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.412. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.412TTM0.4120.000
TTM0.412YOY0.257+0.155
TTM0.4125Y0.334+0.078
5Y0.33410Y0.240+0.094
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4120.389+0.023
TTM0.4120.386+0.026
YOY0.2570.335-0.078
5Y0.3340.442-0.108
10Y0.2400.461-0.221
1.4.2. Debt to Equity Ratio

Measures if Uscom is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Uscom to the Medical Devices industry mean.
  • A Debt to Equity ratio of 70.2% means that company has $0.70 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Uscom Ltd:

  • The MRQ is 0.702. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.702. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.702TTM0.7020.000
TTM0.702YOY0.347+0.355
TTM0.7025Y0.540+0.162
5Y0.54010Y0.357+0.183
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7020.551+0.151
TTM0.7020.554+0.148
YOY0.3470.479-0.132
5Y0.5400.622-0.082
10Y0.3570.674-0.317

2. Market Valuation of Uscom Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Uscom generates.

  • Above 15 is considered overpriced but always compare Uscom to the Medical Devices industry mean.
  • A PE ratio of -4.34 means the investor is paying $-4.34 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Uscom Ltd:

  • The EOD is -2.926. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.343. Based on the earnings, the company is expensive. -2
  • The TTM is -4.343. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.926MRQ-4.343+1.416
MRQ-4.343TTM-4.3430.000
TTM-4.343YOY-8.061+3.718
TTM-4.3435Y-23.563+19.221
5Y-23.56310Y-26.822+3.259
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-2.926-1.077-1.849
MRQ-4.343-1.704-2.639
TTM-4.343-2.081-2.262
YOY-8.061-2.978-5.083
5Y-23.563-2.379-21.184
10Y-26.822-1.726-25.096
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Uscom Ltd:

  • The EOD is -4.811. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -7.139. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -7.139. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.811MRQ-7.139+2.328
MRQ-7.139TTM-7.1390.000
TTM-7.139YOY-14.682+7.543
TTM-7.1395Y260.900-268.039
5Y260.90010Y111.347+149.553
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-4.811-0.932-3.879
MRQ-7.139-1.578-5.561
TTM-7.139-2.973-4.166
YOY-14.682-6.318-8.364
5Y260.900-5.307+266.207
10Y111.347-5.171+116.518
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Uscom is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 3.70 means the investor is paying $3.70 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Uscom Ltd:

  • The EOD is 2.491. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.696. Based on the equity, the company is fair priced.
  • The TTM is 3.696. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.491MRQ3.696-1.205
MRQ3.696TTM3.6960.000
TTM3.696YOY2.679+1.017
TTM3.6965Y8.778-5.082
5Y8.77810Y11.272-2.494
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD2.4911.876+0.615
MRQ3.6962.372+1.324
TTM3.6962.434+1.262
YOY2.6793.217-0.538
5Y8.7783.893+4.885
10Y11.2724.245+7.027
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Uscom Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Uscom Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.012-0.0120%0.012-201%-0.001-88%0.000-4294%
Book Value Per Share--0.0120.0120%0.024-49%0.016-20%0.016-20%
Current Ratio--3.0803.0800%7.045-56%4.427-30%4.876-37%
Debt To Asset Ratio--0.4120.4120%0.257+60%0.334+23%0.240+72%
Debt To Equity Ratio--0.7020.7020%0.347+102%0.540+30%0.357+97%
Dividend Per Share--0.0030.0030%0.016-84%0.004-40%0.002+20%
Eps---0.011-0.0110%-0.008-24%-0.007-37%-0.007-36%
Free Cash Flow Per Share---0.006-0.0060%-0.004-31%-0.003-61%-0.004-38%
Free Cash Flow To Equity Per Share---0.010-0.0100%0.012-185%0.001-1636%0.001-801%
Gross Profit Margin--1.3681.3680%1.336+2%1.503-9%1.429-4%
Intrinsic Value_10Y_max---0.008--------
Intrinsic Value_10Y_min---0.093--------
Intrinsic Value_1Y_max---0.002--------
Intrinsic Value_1Y_min---0.005--------
Intrinsic Value_3Y_max---0.005--------
Intrinsic Value_3Y_min---0.020--------
Intrinsic Value_5Y_max---0.008--------
Intrinsic Value_5Y_min---0.038--------
Market Cap7582228.000-48%11251048.00011251048.0000%15898220.000-29%30368046.080-63%39760225.280-72%
Net Profit Margin---0.972-0.9720%-0.786-19%-0.574-41%-0.745-23%
Operating Margin---1.095-1.0950%-1.038-5%-0.701-36%-0.863-21%
Operating Ratio--2.0952.0950%2.038+3%1.757+19%1.954+7%
Pb Ratio2.491-48%3.6963.6960%2.679+38%8.778-58%11.272-67%
Pe Ratio-2.926+33%-4.343-4.3430%-8.061+86%-23.563+443%-26.822+518%
Price Per Share0.031-48%0.0460.0460%0.065-29%0.124-63%0.163-72%
Price To Free Cash Flow Ratio-4.811+33%-7.139-7.1390%-14.682+106%260.900-103%111.347-106%
Price To Total Gains Ratio-3.338+33%-4.953-4.9530%2.320-313%-99.028+1899%-46.393+837%
Quick Ratio--2.7062.7060%9.437-71%4.129-34%3.899-31%
Return On Assets---0.500-0.5000%-0.247-51%-0.296-41%-0.340-32%
Return On Equity---0.851-0.8510%-0.332-61%-0.454-47%-0.453-47%
Total Gains Per Share---0.009-0.0090%0.028-133%0.003-438%0.002-488%
Usd Book Value--1964007.5111964007.5110%3829427.171-49%2447525.294-20%2460534.591-20%
Usd Book Value Change Per Share---0.008-0.0080%0.008-201%-0.001-88%0.000-4294%
Usd Book Value Per Share--0.0080.0080%0.016-49%0.010-20%0.010-20%
Usd Dividend Per Share--0.0020.0020%0.011-84%0.003-40%0.001+20%
Usd Eps---0.007-0.0070%-0.005-24%-0.004-37%-0.004-36%
Usd Free Cash Flow---1016808.747-1016808.7470%-698640.626-31%-396201.190-61%-635051.133-38%
Usd Free Cash Flow Per Share---0.004-0.0040%-0.003-31%-0.002-61%-0.003-38%
Usd Free Cash Flow To Equity Per Share---0.007-0.0070%0.008-185%0.000-1636%0.001-801%
Usd Market Cap4892053.506-48%7259176.1707259176.1700%10257531.544-29%19593463.331-63%25653297.351-72%
Usd Price Per Share0.020-48%0.0300.0300%0.042-29%0.080-63%0.105-72%
Usd Profit---1671640.938-1671640.9380%-1272536.348-24%-1059183.160-37%-1072395.437-36%
Usd Revenue--1718919.9031718919.9030%1619247.472+6%1981515.787-13%1632487.879+5%
Usd Total Gains Per Share---0.006-0.0060%0.018-133%0.002-438%0.002-488%
 EOD+3 -5MRQTTM+0 -0YOY+3 -335Y+4 -3210Y+7 -29

4.2. Fundamental Score

Let's check the fundamental score of Uscom Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.926
Price to Book Ratio (EOD)Between0-12.491
Net Profit Margin (MRQ)Greater than0-0.972
Operating Margin (MRQ)Greater than0-1.095
Quick Ratio (MRQ)Greater than12.706
Current Ratio (MRQ)Greater than13.080
Debt to Asset Ratio (MRQ)Less than10.412
Debt to Equity Ratio (MRQ)Less than10.702
Return on Equity (MRQ)Greater than0.15-0.851
Return on Assets (MRQ)Greater than0.05-0.500
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Uscom Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.247
Ma 20Greater thanMa 500.031
Ma 50Greater thanMa 1000.030
Ma 100Greater thanMa 2000.035
OpenGreater thanClose0.031
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets5,180
Total Liabilities2,136
Total Stockholder Equity3,044
 As reported
Total Liabilities 2,136
Total Stockholder Equity+ 3,044
Total Assets = 5,180

Assets

Total Assets5,180
Total Current Assets3,742
Long-term Assets1,438
Total Current Assets
Cash And Cash Equivalents 1,879
Short-term Investments 300
Net Receivables 809
Inventory 754
Total Current Assets  (as reported)3,742
Total Current Assets  (calculated)3,742
+/-0
Long-term Assets
Property Plant Equipment 857
Intangible Assets 498
Other Assets 83
Long-term Assets  (as reported)1,438
Long-term Assets  (calculated)1,438
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,215
Long-term Liabilities921
Total Stockholder Equity3,044
Total Current Liabilities
Short-term Debt 263
Accounts payable 278
Other Current Liabilities 674
Total Current Liabilities  (as reported)1,215
Total Current Liabilities  (calculated)1,215
+/-0
Long-term Liabilities
Long term Debt Total 829
Other Liabilities 92
Long-term Liabilities  (as reported)921
Long-term Liabilities  (calculated)921
+/- 0
Total Stockholder Equity
Common Stock38,509
Retained Earnings -39,504
Accumulated Other Comprehensive Income 4,038
Total Stockholder Equity (as reported)3,044
Total Stockholder Equity (calculated)3,044
+/-0
Other
Capital Stock38,509
Cash And Equivalents300
Cash and Short Term Investments 2,179
Common Stock Shares Outstanding 173,341
Current Deferred Revenue674
Liabilities and Stockholders Equity 5,180
Net Debt -787
Net Invested Capital 3,044
Net Tangible Assets 2,534
Net Working Capital 2,527
Property Plant and Equipment Gross 1,852
Short Long Term Debt Total 1,092



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-30
> Total Assets 
15,518
14,604
12,119
9,151
5,935
3,760
3,526
2,831
3,524
1,828
2,815
3,769
2,936
5,712
4,486
5,376
4,139
5,917
5,335
7,993
5,180
5,1807,9935,3355,9174,1395,3764,4865,7122,9363,7692,8151,8283,5242,8313,5263,7605,9359,15112,11914,60415,518
   > Total Current Assets 
15,239
0
11,607
8,380
5,301
3,154
2,899
2,210
2,921
1,325
1,257
2,509
1,824
4,093
3,031
3,899
2,875
3,678
3,451
6,312
3,742
3,7426,3123,4513,6782,8753,8993,0314,0931,8242,5091,2571,3252,9212,2102,8993,1545,3018,38011,607015,239
       Cash And Cash Equivalents 
14,888
13,325
10,545
7,222
4,360
2,509
1,909
1,376
2,125
544
541
1,583
526
2,840
1,664
2,494
1,208
1,905
1,695
1,689
1,879
1,8791,6891,6951,9051,2082,4941,6642,8405261,5835415442,1251,3761,9092,5094,3607,22210,54513,32514,888
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
42
0
0
15
15
3,015
300
3003,0151515004200000000000000
       Net Receivables 
30
317
274
442
297
221
297
55
164
141
98
326
301
268
196
249
583
929
846
736
809
809736846929583249196268301326981411645529722129744227431730
       Inventory 
79
198
329
225
239
112
219
329
214
191
191
217
526
419
492
495
511
829
895
872
754
75487289582951149549241952621719119121432921911223922532919879
       Other Current Assets 
242
350
459
491
405
312
474
450
417
448
427
383
472
567
638
661
39
657
621
515
675
67551562165739661638567472383427448417450474312405491459350242
   > Long-term Assets 
279
0
512
771
634
605
627
621
604
504
1,558
1,261
1,112
1,619
1,455
1,477
1,264
2,239
1,884
1,681
1,438
1,4381,6811,8842,2391,2641,4771,4551,6191,1121,2611,5585046046216276056347715120279
       Property Plant Equipment 
114
158
156
356
246
154
87
96
93
68
52
38
46
75
119
238
223
1,658
1,331
1,120
857
8571,1201,3311,6582232381197546385268939687154246356156158114
       Intangible Assets 
55
146
253
292
377
448
539
525
510
435
1,507
1,223
1,066
1,544
1,336
1,155
957
498
470
477
498
4984774704989571,1551,3361,5441,0661,2231,50743551052553944837729225314655
       Other Assets 
10
10
3
23
10
4
0
0
0
0
0
0
0
0
0
83
83
83
83
83
83
8383838383830000000004102331010
> Total Liabilities 
75
312
372
641
438
354
469
381
389
358
461
450
648
774
708
531
651
2,495
2,257
2,058
2,136
2,1362,0582,2572,49565153170877464845046135838938146935443864137231275
   > Total Current Liabilities 
75
282
338
593
379
282
368
294
291
231
438
428
615
756
683
491
613
998
949
896
1,215
1,21589694999861349168375661542843823129129436828237959333828275
       Short-term Debt 
5
0
13
6
9
4
0
0
0
0
0
0
0
0
0
0
0
187
189
220
263
263220189187000000000004961305
       Accounts payable 
18
151
99
308
78
45
143
92
54
38
108
62
180
73
112
133
282
270
136
154
278
278154136270282133112731806210838549214345783089915118
       Other Current Liabilities 
70
131
226
278
293
233
225
202
236
194
330
367
435
683
571
358
331
541
624
522
674
67452262454133135857168343536733019423620222523329327822613170
   > Long-term Liabilities 
0
0
34
49
59
72
102
88
98
127
23
22
33
18
26
40
38
1,497
1,309
1,162
921
9211,1621,3091,4973840261833222312798881027259493400
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,430
1,241
1,092
829
8291,0921,2411,43000000000000000000
       Other Liabilities 
0
30
34
48
59
72
102
87
98
127
23
22
33
18
26
40
38
67
68
70
92
9270686738402618332223127988710272594834300
> Total Stockholder Equity
15,443
14,293
11,747
8,509
5,496
3,406
3,056
2,450
3,136
1,470
2,355
3,319
2,289
4,938
3,778
4,845
3,488
3,422
3,078
5,935
3,044
3,0445,9353,0783,4223,4884,8453,7784,9382,2893,3192,3551,4703,1362,4503,0563,4065,4968,50911,74714,29315,443
   Common Stock
16,599
16,644
16,644
16,644
16,644
16,644
17,223
18,345
21,377
21,527
23,638
26,006
26,019
30,309
30,332
33,255
33,301
34,197
34,666
39,137
38,509
38,50939,13734,66634,19733,30133,25530,33230,30926,01926,00623,63821,52721,37718,34517,22316,64416,64416,64416,64416,64416,599
   Retained Earnings -39,504-36,913-34,940-34,016-32,685-31,295-29,334-27,534-25,619-24,403-22,882-21,511-19,686-17,000-15,243-14,143-11,968-8,771-4,8970-1,157
   Capital Surplus 000000000000000000000
   Treasury Stock000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
1,716
81
63
2,780
2,885
2,872
3,241
3,352
3,711
101
1013,7113,3523,2412,8722,8852,78063811,71600000000000



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.